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Validation of the Portuguese version of 
the Psychotic Symptom Rating Scales 
(PSYRATS)
The Psychotic Symptom Rating Scales (PSYRATS) is a 
clinical assessment tool that focuses on the detailed 
measurement of delusions and hallucinations in patients 
with psychosis. The goal of this study was to examine the 
psychometric properties of the Portuguese version of the 
PSYRATS. A sample of 92 outpatients suffering from 
schizophrenia or schizoaffective disorders and presenting 
persistent psychotic symptoms was assessed using the 
PSYRATS and the Positive and Negative Syndrome Scale 
(PANSS). Good inter-rater reliability, test-retest reliability, 
concurrent validity and internal consistency were found. 
Factor analysis of the auditory hallucinations scale items 
disclosed a four-factor solution: emotion characteristics and 
disruption factor (factor 1), a physical characteristics factor 
(factor 2), a control characteristics factor (factor 3) and a 
cognitive attribution factor (factor 4). Regarding the 
delusions scale items, a two-factor solution was found: 
cognitive interpretation and disruption factor (factor 1) and 
an emotional characteristics (factor 2). The Portuguese 
version of the PSYRATS partially replicates previously 
published results in other countries. 
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medición detallada de delirios y alucinaciones en pacientes 
con psicosis. El objetivo de este estudio fue examinar las 
propiedades psicométricas de la versión en portugués de la 
PSYRATS. Se evaluó una muestra de 92 pacientes ambula-
torios con la PSYRATS y la Escala de Síndromes Positivo y 
Negativo (PANSS). Los pacientes padecían de esquizofrenia 
o trastornos esquizoafectivos y presentaban síntomas psi-
cóticos persistentes. Se encontró una buena fiabilidad entre 
evaluadores, fiabilidad de repetibilidad, validez concurrente 
y consistencia interna. El análisis factorial de los ítems de 
la escala de alucinaciones auditivas reveló una solución de 
cuatro factores: características de la emoción y factor de 
perturbación (factor 1), un factor de características físicas 
(factor 2), un factor de características de control (factor 3) y 
un factor de atribución cognitiva (factor 4). En cuanto a los 
ítems de la escala de delirios, se encontró una solución de 
dos factores: un factor de interpretación cognitiva y pertur-
bación (factor 1) y un factor de características emocionales 
(factor 2). La versión en portugués de la PSYRATS replicó 
parcialmente resultados publicados anteriormente en otros 
países. 
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InTRoducTIon
Jaspers first conceptualized the descriptive approach in 
psychopathology at the beginning of the 20th century. He 
emphasized the importance of the descriptions of the pa-
tients’ experiences, which he called “phenomenology”1. 
However, the emergence of modern psychiatric classifica-
tion systems (with operational diagnostic criteria) led to an 
emphasis on the nosological diagnosis and, at the end of the 
century, the quantitative studies became the prime con-
cern2.
In the last years, we are facing the re-emergence of the 
Descriptive Psychopathology. Indeed, several authors at-
tempt to include again in their studies a more descriptive 
component of Psychopathology. Among these, the investi-
gation of the several dimensions of delusions and hallucina-
tions are highlighted3,4.
Currently, there are several different scales that measure 
the presence and severity of symptoms of psychosis5. The 
Positive and Negative Syndrome Scale (PANSS)6 is frequently 
used to measure the symptom severity with focus on many 
different experiences and behaviours. Therefore, it restricts 
the detailed measurement of specific symptoms such as 
delusions and hallucinations.
The Psychotic Symptom Rating Scales (PSYRATS)7 was 
developed in order to improve the measurement of the core 
dimensions of psychotic symptoms (hallucinations and delu-
sions) and it is typically used in research studies and clinical 
settings focused on people with psychosis. PSYRATS has also 
been used in several psychotic conditions, including schizo-
phrenic spectrum disorder8, first episode9 and intellectual 
disability with psychosis10. It is validated in several languag-
es, namely in Spanish11, French12 and Malay13 and has been 
included as an outcome measure of several clinical trials of 
psychological interventions for psychosis14-23.
The PSYRATS is a 17-item instrument included in two 
separate subscales: one for delusions (six items) and other 
for hallucinations (eleven items), rated from zero to four7. In 
the original study, a three-factor structure was found in the 
factor analysis for the auditory hallucination scale: emo-
tional characteristics, physical characteristics and cognitive 
interpretation. It was also found a two-factor structure for 
the delusion scale: emotional characteristics and cognitive 
interpretation. 
The Portuguese population only have available a few 
instruments to assess schizophrenia diagnosis and its severity. 
Furthermore, no validated self-report measures are yet available 
to specifically assess hallucination and delusion dimensions. 
The aim of this study was to examine the psychometric 
properties of the Portuguese version of PSYRATS in a sample 
of patients suffering from schizophrenia-spectrum disorders. 
The PSYRATS was evaluated both for inter-rater reliability 
and inter-relationships of the items. Moreover, construct 
and concurrent validity were examined. 
MATERIAl And METhodS
Recruitment 
To be included in the studies, participants had to meet 
the DSM-5 criteria for schizophrenia or schizoaffective 
disorders. Participants had no recent change in antipsychotic 
medication. Participants were recruited among patients 
admitted to Hospital Júlio de Matos (a psychiatric hospital) 
and Hospital Santa Maria (a general hospital). The two 
populations from which the sample was drawn received 
approval by the local ethics committees and all participants 
signed an informed consent form. 
Participants
Ninety-two participants took part in the study. Eligibil-
ity depended on the presence of persistent delusions or au-
ditory hallucinations before consent was obtained. Diagno-
ses were extracted from current clinical records and 
confirmed by experienced clinicians. All participants spoke 
Portuguese fluently. 
Instruments
Patients were assessed using the PSYRATS and the 
PANSS. The PSYRATS is a 17-item, five-point scale (0–4), 
multidimensional measure of delusions and auditory 
hallucinations. The items for auditory hallucinations are: 
frequency, duration, location, loudness, beliefs about origin, 
negative content, intensity of negative content, amount of 
distress, intensity of distress, disruption of life and control. 
The items for delusions are: amount of preoccupation, 
duration of preoccupation, conviction, amount of distress, 
intensity of distress and disruption of life. The interview with 
the PSYRATS usually takes about 30 to 60 minutes to 
complete. The interview and rating should be completed by 
psychiatrists, clinical psychologist or other mental health 
professional with experience on psychiatric symptoms rating 
scales.
The original English version of the PSYRATS was 
independently translated by the two first authors (NR and 
DT) and compared until full agreement was found. Semantic 
equivalence was inspected with an English language expert. 
The main author of the original version authorized the 
translation.
The PANSS is a 30-item, seven point (1–7) rating 
instrument used for the assessment of symptom phenomena 
associated with schizophrenia. 
For all patients, symptom rating assessments were 
performed by clinicians trained to reliably administer these 
measures.
Statistical analysis
All analyses were conducted using the International 
Business Machines’ Statistical Package for the Social Scienc-
es (IBM SPSS) version 20. The factor structure of the scales 
was evaluated by principal component factor analysis with a 
single varimax rotation with Kaiser Normalization. In-
ter-rater reliability was assessed by intraclass correlations 
(ICCs). Significance test results are quoted as two-tailed 
probabilities. Associations between PSYRATS and PANSS 
items were examined using Spearman rank-based correla-
tions.
RESulTS
Sample
Data was collected from ninety-two participants (39,5% 
females). Seventy-six (82.6%) patients were diagnosed with 
schizophrenia, fourteen (15.2%) with schizoaffective disor-
der and two (2,2%) with psychosis not otherwise specified. 
All patients had either auditory verbal hallucinations or de-
lusions. 85 (92,4%) of the patients had delusions and 68 
(73.9%) had auditory hallucinations. 61 patients had both 
delusions and auditory hallucinations (66.3%). The mean age 
of the participants was 39.43 (SD=12,32). The mean time of 
illness duration was 11,45 (SD=10,12). All patients were re-
ceiving antipsychotic (CPZ equivalents mean = 580.07; 
SD=332.10). 
Inter-rater reliability
Thirty-nine participants (n=25 males) were selected 
conveniently to independent rating by a second rater. 
Intraclass correlations for the items of the auditory 
hallucinations scale of the PSYRATS were excellent, ranging 
between 0.96 to 1.00. For the delusions scale, the ICCs were 
also excellent, between 0.95 to 1.00. Average ICC of the 
auditory hallucination scale was 0.99 and of the delusions 
scale was 0.98.
Test-retest reliability
Thirty-nine participants were interviewed 2-weeks after 
the first interview to establish test-retest reliability. Pearson 
product-moment correlation coefficient between test and 
retest was 0.57 (p<0,01) for the auditory hallucinations scale 
and 0.51 (p<0,01) for the delusions scale. The mean score for 
the auditory hallucinations scale was 27.28 (SD=11.66) at 
the pre-test and 16.87 (SD=15.61) at the retest and the 
mean score for the delusions scale was 16.87 (SD=5.89) at 
the pre-test and 11.77 (SD=9.28), which may represent 
treatment effects.
Internal consistency
Cronbach’s alpha values for the auditory hallucinations 
scale was 0.96 and for the delusions scale was 0.89, and thus 
excellent internal consistency. Removing any item would 
decrease the internal consistency in both scales. The 
corrected item-total correlation ranged between 0.72 and 
0.85 for the auditory hallucination scale and between 0.60 
and 0.80 for the delusions scale. The inter-item correlations 
for the auditory hallucinations items were between 0.43 and 
0.95 and for the delusions scale were between 0.33 and 0.93.
concurrent validity
Pearson product-moment correlations coefficients were 
calculated between the PSYRATS scales and the positive 
subscale and items of the PANSS (table 1). The auditory ha-
llucinations scale was significantly correlated with the 
PANNS hallucinations item, negative scale, general psycho-
pathology and total score. The delusions scale was signifi-
cantly correlated with PANNS delusions and suspiciousness/
persecution items, positive scale, negative scale, general 
psychopathology and total score.
Factor analysis
The construct validity of the PSYRATS scales was 
examined using a principal components factor analysis with 
varimax rotation. Only the participants that reported 
auditory hallucinations were included in the factor analysis 
of the PSYRATS hallucinations scale items. Also, only the 
Table 1 correlations of the PSYRATS scales and the PAnnS
PAnSS
PSYRATS delusions hallucinations Persecution Positive Scale negative Scale General Total Score
Auditory 
hallucinations 
Scale
-0.082 0.6022 0.077 0.162 0.2171 0.2782 0.2731
delusions Scale 0.5862 0.2241 0.3962 0.5342 0.2281 0.4622 0.4982
1p<0.05, 2p<0.01
participants who reported delusions were included in the 
factor analysis of the PSYRATS delusions scale items. Only 
factors with an eigenvalue of 1 or greater (Kaiser criterion) 
were retained. Regarding the auditory hallucinations scale 
items, a four-factor solution with eigenvalues greater than 
1 was found and explained 71.28% of the total variance. The 
distress, disruption to life and negative content items loaded 
onto one factor; the frequency and duration items loaded 
on a second; the loudness and controllability items loaded 
onto a third; and location and origin of voice items loaded 
onto a fourth (table 2). These four factors could be identified 
as an emotion characteristics and disruption factor (factor 
1), a physical characteristics factor (factor 2), a control 
characteristics factor (factor 3) and a cognitive attribution 
factor (factor 4).
Regarding the delusions scale items, a two-factor 
solution with eigenvalues greater than 1 was found and 
explained 75.92% of the total variance. The amount of 
preoccupation, duration of preoccupation, conviction and 
disruption to life items loaded onto one factor and the 
distress items loaded onto another (table 3). These two 
factors could be identified as a cognitive interpretation and 
disruption factor (factor 1) and one emotional characteristic 
(factor 2).
dIScuSSIon
The current study presents the factor structure and the 
relationship between the PSYRATS and PANSS in a population 
of Portuguese speaking patients having persistent psychotic 
symptoms.
The factor structure of the delusions scale of the 
PSYRATS is the same as in the original study7, German8, and 
French12. The factor structure of the hallucinations scale 
shows a four-factor structure. The original study has 
disclosed a three-factor structure7. The factors we found 
were: Emotion characteristics and disruption factor (factor 
1), Physical characteristics factor (factor 2), a control 
characteristics factor (factor 3) and a cognitive attribution 
factor (factor 4). These are very similar to those found in the 
French and German validations8,12.
As in previous validation studies, an emotional factor 
appears clearly, as well as a cognitive attribution factor and 
a physical characteristics factor7,8,12. A fourth factor appears 
in other validations but not in the original study of Psyrats8,12. 
In the French version the fourth factor is disruption and 
volume12, but in the German version the fourth factor is a 
control characteristics factor8, as it is in our study. 
It is our understanding that control is a fundamental 
dimension for the comprehension of hallucinations in psy-
chotic disorders. There is consistent evidence demonstrating 
that the hallucinatory experience is not exclusively depen-
dent of perceptual processes, but a phenomenon that highly 
relies on top-down cognitive control processes24. This is the 
reason why interventions based on cognitive control have a 
positive impact in these symptoms25.
Table 2 Factor loadings for auditory 
hallucinations scale
Factors
1 2 3 4
Frequency 0.164 0.853 -0.191 0.102
Duration 0.216 0.813 0.214 0.068
Location 0.173 -0.070 0.006 0.833
Loudness 0.076 -0.145 0.861 -0.017
Origin of voice -0.123 0.383 0.031 0.667
Amount of 
negative content
0.824 -0.168 0.194 0.042
Degree of negative 
content
0.823 0.174 0.052 0.118
Amount of distress 0.887 0.233 0.112 -0.085
Intensity of distress 0.848 0.189 0.266 -0.014
Disruption to life 0.552 0.219 -0.212 0.099
Controllability 0.217 0.409 0.625 0.085
Cumulative 
percentage of 
variation 
30.35 47.85 60.42 71.28
Table 3 Factor loading for delusions scale
Factors
1 2
Amount of preoccupation 0.808 0.176
Duration of preoccupation 0.754 0.400
Conviction 0.786 -0.036
Amount of distress 0.189 0.942
Intensity of distress 0.152 0.962
Disruption to life 0.667 0.455
Cumulative percentage of 
variation
39.04 75.92
In most validation studies, location and beliefs re-origin 
items usually loaded on a cognitive attribution factor; 
negative content and distress items usually loaded on an 
emotion characteristics factor; and frequency and duration 
items usually loaded on a physical characteristics factor7,8,12. 
The differences across validations appear mostly in 
disruption, volume and control items that appear in different 
factors, depending on the study. 
The factor analysis of our study encountered the same 
difficulties as previous studies did when replicating the 
factorial structure of the original version of PSYRATS 
hallucinations’ scale. Steel5 also found a four-factor 
structure in his study and pointed out these differences 
between the original structure and the replication studies 
might reflect the lack of a clear understanding of the 
dimensions of hallucinatory experience. He also refers that 
further research is needed to clarify the best use of potential 
subscales. 
Favrod et al.12 also gives an explanation for these 
differences between the factor structure of the replication 
studies and the original validation study of PSYRATS. 
According to the authors, different evaluations of PSYRATS 
have been carried out with dissimilar participant populations 
with psychotic symptoms and with a differential response to 
psychiatric treatment, which can be confounding factors. 
Regarding concurrent validity, we also found several as-
sociations with the PANSS. While the delusions scale was 
associated with the full positive symptoms scale and with 
selected items of delusions and suspiciousness/persecution, 
auditory hallucinations was selectively associated only with 
the hallucinations item of the PANSS, but not with the pos-
itive symptoms scale. This results shows that the PSYRATS 
scale appear to selectively and accurately address these psy-
chotics symptoms, but add additional relevant information.
Regarding the limitations of the study, we selected 
participants mainly with persistent psychotic symptoms, 
which may prevent that results and conclusions can be 
applied to other conditions associated to psychosis. In what 
concerns external validity, the smaller number of participants 
with schizoaffective disorder compared to participants with 
schizophrenia might also have been an important limitation. 
concluSIonS
In conclusion, the Portuguese version of the PSYRATS 
partially replicates the original validation study and previous 
evaluations of the scale in other languages. The results show 
that the Portuguese version of the PSYRATS seems to 
adequately measure relevant dimensions of the psychotic 
symptoms. Further research is needed to clarify the different 
dimensions (factors) of the PSYRATS Hallucinations scale.
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